GMP Manufacturing - Clinical Trial Materials

Flexible, fast and precise, Frontage operates under current Good Manufacturing Practices (cGMP) to produce Phase I & II Clinical Trial Materials in small to large batch sizes with quick scale up to fit your late phase clinical needs.

 

The cGMP manufacturing facility is designed to produce solid oral dosage forms, as well as semi-solid, liquid and aseptically filled liquid and powder sterile products containing either non-potent or potent compounds.

 

The Frontage Clinical Trial Materials team develops oral solid dose, liquids (ophthalmic drops and injectables), as well as alternate dosage forms such as nasal sprays.  For more detail, see our Finished Product Development page.

 

Each of our skilled scientific staff members have significant industry experience and training from the bench to the marketplace. This expertise, combined with our team’s commitment to the success of your project, dramatically simplifies the implementation and scale-up of any process.